Rifaximin Effective for Multiple Symptoms in Irritable Bowel Syndrome With Diarrhea
Researchers analyzed the efficacy of rifaximin for relieving IBS-D symptoms, specifically abdominal pain, bloating, and bowel movement urgency.
Researchers analyzed the efficacy of rifaximin for relieving IBS-D symptoms, specifically abdominal pain, bloating, and bowel movement urgency.
The American Gastroenterological Association issued a clinical practice update outlining dietary best practices for patients with irritable bowel syndrome.
Researchers examined the rate of inpatient services in individuals with irritable bowel syndrome who used vs did not use cannabis.
Investigators assessed the specificity and sensitivity of confocal laser endomicroscopy for identifying wheat sensitivity in patients with IBS.
Given the overall prevalence of irritable bowel syndrome, it is important for clinicians to be able to distinguish postinfectious irritable bowel syndrome from its other subtypes.
Investigators tested the hypothesis that psyllium can reduce the increase in colonic gas induced by inulin in patients with IBS.
Researchers conducted a meta-analysis to assess the efficacy of a low FODMAP diet in patients with IBS and compared this efficacy with other dietary interventions.
Researchers reviewed and summarized the safety and efficacy of individual antispasmodics available in North America for the treatment of chronic abdominal pain.
Researchers assessed the stability of the virome over time, the effect of diet and genetics, the impact of the virome on host gene expression, and whether specific viruses are associated with IBS subtypes.
Researchers provided practical tips and management approach strategies for the treatment of severe irritable bowel syndrome.